Faslodex (fulvestrant) is a prescription medicine used for people with certain types of breast cancer. Faslodex is given as an injection into the buttocks (gluteal area) by a health care provider in a ...
The effects of neoadjuvant chemotherapy in postmenopausal women on TSH and fT4, when compared with untreated postmenopausal women with breast cancer, are summarized in (c). Panel A highlights that ...
A 52-year-old woman, 3 years into aromatase inhibitor therapy for stage I hormone receptor–positive breast cancer, reports severe vasomotor symptoms, insomnia, brain fog, arthralgias, dyspareunia, and ...
As misinformation about women’s health spreads faster than ever, doctors say new research on the risks of hormonal birth control underscores the challenge of communicating nuance in the social media ...
—With data on the subject lacking, investigators in Milan sought to determine how well fertility is preserved in women with hormone receptor-positive breast cancer treated with hormonal therapy (HT).
Menopause isn’t just about hot flushes and brain fog. It’s also a time when hormonal changes can influence breast cancer risk. In the run-up to global Breast Cancer Awareness Month this October, Cansa ...
WELCOME BACK. MARCH IS INTERNATIONAL WOMEN’S MONTH, AND THIS MORNING WE’RE HIGHLIGHTING AN IMPORTANT BUT OFTENTIMES CONFUSING TOPIC HORMONES AND HOW THEY RELATE TO CANCER RISKS IN WOMEN HERE TO HELP ...
Most gynecologic oncologists and radiation oncologists would consider prescribing hormone therapy for patients with cervical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results